The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis
Open accessAbstract
Chemokines are signaling peptides which regulate cell trafficking and provide control of the tissue-specific cell homing. In the skin, chemokines are secreted both by the resident cells such as keratinocytes, melanocytes, fibroblasts, dendritic cells and mast cells, as well as by infiltrated cells - lymphocytes, eosinophils, and monocytes. Chemokines, together with cytokines, participate in induction and maintenance of inflammation in the skin and regulate the composition of the cellular infiltrates. Inflammation within the skin is a feature shared by atopic dermatitis and psoriasis, two of the most common dermatoses. Accumulation of activated mast cells in the affected skin is seen both in atopic dermatitis and in psoriasis. This paper presents a concise overview of the current knowledge on the role chemokines have in pathogenesis of atopic dermatitis, psoriasis, and mastocytosis, a disease caused directly by the accumulation and activation of mast cells in the skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
Borish, L. C., & Steinke, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.108 · Cited by 879
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D. P., Warnke, R., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 841
CCL27–CCR10 interactions regulate T cell–mediated skin inflammation
Homey, B., Alenius, H., Müller, A., Soto, H., Bowman, E. P., Yuan, W., McEvoy, L., Lauerma, A. I., Assmann, T., Bünemann, E., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-157 · Cited by 807
Theoharides, T. C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Miniati, A., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.014 · Cited by 680
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin
Steinhoff, M., Neisius, U., Ikoma, A., Fartasch, M., Heyer, G., Skov, P. S., Luger, T. A., & Schmelz, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06176.2003 · Cited by 653
Cytokines and chemokines orchestrate atopic skin inflammation
Homey, B., Steinhoff, M., Ruzicka, T., & Leung, D. Y. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.047 · Cited by 579
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6621 · Cited by 537
Psoriasis pathophysiology: current concepts of pathogenesis
Krueger, J. G., & Bowcock, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.031120 · Cited by 523
Reiss, Y., Proudfoot, A. E., Power, C. A., Campbell, J. J., & Butcher, E. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1541 · Cited by 517
(2010) · Atlas of Immunology, Third Edition · doi:10.1201/ebk1439802687-c10 · Cited by 516
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells
Morales, J., Homey, B., Vicari, A. P., Hudak, S., Oldham, E., Hedrick, J., Orozco, R., Copeland, N. G., Jenkins, N. A., McEvoy, L. M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14470 · Cited by 507
Recent Advances in Chemokines and Chemokine Receptors
Zlotnik, A., Morales, J., & Hedrick, J. A. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i1.10 · Cited by 407
Dieu-Nosjean, M.-C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J.-J., Vicari, A., Lebecque, S., Dezutter-Dambuyant, C., Schmitt, D., Zlotnik, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.705 · Cited by 378
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis
Nomura, I., Gao, B., Boguniewicz, M., Darst, M. A., Travers, J. B., & Leung, D. Y. M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.049 · Cited by 332
Homey, B., Wang, W., Soto, H., Buchanan, M. E., Wiesenborn, A., Catron, D., Müller, A., McClanahan, T. K., Dieu-Nosjean, M.-C., Orozco, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3465 · Cited by 332
Zhou, X., Krueger, J. G., Kao, M.-C. J., Lee, E., Du, F., Menter, A., Wong, W. H., & Bowcock, A. M. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00157.2002 · Cited by 295
Psoriasis—recent advances in understanding its pathogenesis and treatment
Krueger, G., & Ellis, C. N. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.04.035 · Cited by 245
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
Toichi, E., Torres, G., McCormick, T. S., Chang, T., Mascelli, M. A., Kauffman, C. L., Aria, N., Gottlieb, A. B., Everitt, D. E., Frederick, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4917 · Cited by 229
Rottman, J. B., Smith, T. L., Ganley, K. G., Kikuchi, T., & Krueger, J. G. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780242 · Cited by 213
Targeting chemokine receptors in chronic inflammatory diseases: An extensive review
Koelink, P. J., Overbeek, S. A., Braber, S., de Kruijf, P., Folkerts, G., Smit, M. J., & Kraneveld, A. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.008 · Cited by 169
Chemokine blockers – therapeutics in the making?
Wells, T. N. C., Power, C. A., Shaw, J. P., & Proudfoot, A. E. I. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.001 · Cited by 167
Rau, R. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii70 · Cited by 159
Gottlieb, A. B., Masuda, S., Ramamurthi, R., Abdulghani, A. A., Romano, P., Chaudhari, U., Dooley, L. T., Fasanmade, A. A., & Wagner, C. L. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.10 · Cited by 153
Chemokine receptors in the pathogenesis and therapy of psoriasis
Mabuchi, T., Chang, T. W., Quinter, S., & Hwang, S. T. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.11.007 · Cited by 120
Frenzel, L., & Hermine, O. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.013 · Cited by 109
Aung, G., Niyonsaba, F., Ushio, H., Kajiwara, N., Saito, H., Ikeda, S., Ogawa, H., & Okumura, K. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03395.x · Cited by 89
Chemokine networks in atopic dermatitis: traffic signals of disease
Pivarcsi, A., & Homey, B. (2005) · Current Allergy and Asthma Reports · doi:10.1007/s11882-005-0068-y · Cited by 79
Raychaudhuri, S. P., Jiang, W.-Y., & Farber, E. M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04219.x · Cited by 68
Proteinase‐activated receptor‐2 mediates itch: a novel pathway for pruritus in human skin
Steinhoff, M., Neisius, U., Ikoma, A., Fartasch, M., Heyer, G., Skov, P. S., Luger, T. A., & Schmelz, M. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.0212co.x · Cited by 51
Kinney, T. P., Rawlins, M., Kozarek, R. A., France, R., & Patterson, D. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07286.x · Cited by 50
The CX3CL1–CX3CR1 system and psoriasis
Plant, D., Young, H. S., Watson, R. E. B., Worthington, J., & Griffiths, C. E. M. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00486.x · Cited by 29
Siniewicz‐Luzeńczyk, K., Stańczyk-Przyłuska, A., & Zeman, K. (2013) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2013.38356 · Cited by 26
Cited by
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
The Role of Chemokines in Wound Healing
Ridiandries, A., Tan, J. T. M., & Bursill, C. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103217 · Cited by 475
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Jiang, Y., Tsoi, L. C., Billi, A. C., Ward, N. L., Harms, P. W., Zeng, C., Maverakis, E., Kahlenberg, J. M., & Gudjonsson, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.142067 · Cited by 348
Interleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
Keratinocytes: innate immune cells in atopic dermatitis
Chieosilapatham, P., Kiatsurayanon, C., Umehara, Y., Trujillo-Paez, J. V., Peng, G., Yue, H., Nguyen, L. T. H., & Niyonsaba, F. (2021) · Clinical and Experimental Immunology · doi:10.1111/cei.13575 · Cited by 217
Metadata
- Authors
- Nedoszytko, B., Sokołowska-Wojdyło, M., Ruckemann-Dziurdzińska, K., Roszkiewicz, J., & Nowicki, R. J.
- Venue
- Advances in Dermatology and Allergology
- Publisher
- Termedia Sp. z.o.o.
- Published
- 2014
- Volume
- 2
- Issue
- 2
- Pages
- 84-91
- ISSN
- 0860-6218 (ISSN-L)
- 1642-395X
- OpenAlex
- W2120115895
- Cited by
- 292
- References
- 38
- FWCI
- 21.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.